Abstract:
A system and method for calibrating a helmet with a plurality of optical markers thereon is provided. The system includes a memory, a camera and a mechanical actuator to which the helmet is connected during the calibration process so that it is movable relative to the camera. A processor is connected to the camera and the mechanical actuator and is programmed to control the mechanical actuator to move the helmet relative to the camera through a plurality of discrete points on a calibration target pattern and at each of the discrete points, control the camera to take a digital image. For each of the images, the processor determines the position of at least one of the plurality of markers in the image and uses the position of the at least one marker in the image together with the position of the mechanical actuator to calibrate the helmet.
Abstract:
This invention relates to a single cell assay for determining the effect of chromosomal contact on the transcriptional activity of genes of interest in a cell and to methods of silencing gene expression in a cell by way of perturbing gene regulatory elements which are engaged in chromosomal contact.
Abstract:
A system and method for calibrating a camera includes an energy source and a camera to be calibrated, with at least one of the energy source and the camera being mounted on a mechanical actuator so that it is movable relative to the other. A processor is connected to the energy source, the mechanical actuator and the camera and is programmed to control the mechanical actuator to move at least one of the energy source and the camera relative to the other through a plurality of discrete points on a calibration target pattern. The processor further, at each of the discrete points, controls the camera to take a digital image and perform a lens distortion characterization on each image. A focal length of the camera is determined including any lens connected to the camera and an extrinsic camera position for each image is then determined.
Abstract:
The invention relates to an apparatus, method and system for measuring and optionally detecting an electrical discharge having a discharge magnitude, wherein the electrical discharge causes a corresponding emission of optical radiation. The apparatus embodies the system and method in accordance with the invention, wherein the method comprises measuring electrical discharge by firstly storing pre-determined calibration data comprising calibrated quantitative measurement values associated with magnitudes of electrical discharge and detector parameters corresponding thereto, the detector parameters being operating parameters associated with the optical detector, receiving and processing a particular detector parameter with the stored calibration data to detect an electrical discharge, and determine a quantitative measurement associated with the magnitude of the detected electrical discharge.
Abstract:
A system and method for calibrating a camera includes an energy source and a camera to be calibrated, with at least one of the energy source and the camera being mounted on a mechanical actuator so that it is movable relative to the other. A processor is connected to the energy source, the mechanical actuator and the camera and is programmed to control the mechanical actuator to move at least one of the energy source and the camera relative to the other through a plurality of discrete points on a calibration target pattern. The processor further, at each of the discrete points, controls the camera to take a digital image and perform a lens distortion characterisation on each image. A focal length of the camera is determined including any lens connected to the camera and an extrinsic camera position for each image is then determined.
Abstract:
The present invention relates to a pharmaceutical composition for preventing and/or treating dementia comprising extracts of Monsonia sp.; a food composition for preventing and/or improving dementia comprising extracts of Monsonia sp.; and a method of preparing an extract of Monsonia sp. with excellent inhibitory effect on the formation of β-amyloid. The plant extract can inhibit the formation of β-amyloid which has been known as a factor causing the dementia, especially Alzheimer's disease, thereby being used for preventing, improving and/or treating the dementia.
Abstract:
A gas borne substance sampling device (10) includes a housing (12) through which gas can be passed, and a holder (14) for gas borne substance capturing material. The holder (14) is located or locatable inside the housing (12) to contact the capturing material with gas passing through the housing (12). The device (10) has a sampling condition in which at least a major portion of the holder (14) is protected inside or covered by the housing (12) and an analysis condition in which at least a portion of the holder (14) is exposed or outside the housing (12).
Abstract:
The present invention provides a novel strain of Streptomyces sp. having Accession Number PTA 973 and a process for the preparation of an alkaline protease inhibitor employing the said strain.
Abstract:
1 A pharmaceutical composition which contains an extract obtainable from a plant of the genus Trichocualon or Hoodia containing an appetite suppressant agent having the formula (1). A process for obtaining the extract and a process for synthesizing compound (1) and its analogues and derivatives is also provided. The invention also extends to the use of such extracts and compound (1) and its analogues for the manufacture of medicaments having appetite suppressant activity. The invention further provides novel intermediates for the synthesis of compound (1).
Abstract:
The present invention relates to method of inhibition of cellular endocytosis by treating the cells with compound of formula-1 Diphenylthio urea and Diphenylurea derivatives. Said invention also discloses method of treatment of infectious diseases, neurological disease, cancer, kidney disease in a subject in need thereof by administering therapeutically effective concentration of compounds of Formula-1, Diphenylthio urea and Diphenylurea derivatives which are effective inhibitors of cellular endocytosis. Said invention also discloses compounds of Formula-1, Diphenylthio urea and Diphenylurea derivatives and pharmaceutical composition comprising compounds of Formula-1, Diphenylthio urea and Diphenylurea derivatives along with suitable excipients.